# Sanaria Inc. clinical trials: 29 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 29 trials with Sanaria Inc. as lead sponsor, 4 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Sanaria Inc.: 29 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/sanaria-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 29
- Recruiting or not yet: 4
- Read on: November 19, 2026

## Trials

The 25 newest of 29, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 28, 2026 | NCT07730177 | Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso | Sanaria Inc. | Phase 1 | Not yet recruiting | Malaria (Plasmodium Falciparum) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07730177) |
| June 30, 2026 | NCT07675785 | PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali | Sanaria Inc. | Phase 2 | Recruiting | Malaria (Plasmodium Falciparum) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07675785) |
| February 4, 2026 | NCT07385287 | Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults | Sanaria Inc. | Phase 2 | Recruiting | Malaria (Plasmodium Falciparum) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07385287) |
| March 6, 2025 | NCT06862453 | Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults | Sanaria Inc. | Phase 1 | Recruiting | Malaria Falciparum | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06862453) |
| October 22, 2024 | NCT06652737 | Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso | Sanaria Inc. | Phase 1 | Completed | Malaria Falciparum, Malaria Infection | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06652737) |
| November 3, 2022 | NCT05604521 | A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI | Sanaria Inc. | Phase 1 | Terminated | Malaria, Malaria,Falciparum | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05604521) |
| July 19, 2021 | NCT04966871 | Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults | Sanaria Inc. | Phase 1 | Completed | Malaria | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04966871) |
| June 25, 2021 | NCT04940130 | PfSPZ Vaccine Trial in Malian Children | Sanaria Inc. | Phase 2 | Completed | Malaria, Malaria,Falciparum | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04940130) |
| July 18, 2018 | NCT03590340 | Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea | Sanaria Inc. | Phase 1 | Completed | Malaria | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03590340) |
| May 11, 2018 | NCT03521973 | Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children | Sanaria Inc. | Phase 2 | Completed | Malaria | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03521973) |
| April 19, 2018 | NCT03503058 | Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against... | Sanaria Inc. | Phase 2 | Completed | Malaria | 345 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03503058) |
| February 5, 2018 | NCT03420053 | Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults | Sanaria Inc. | Phase 1 | Completed | Malaria, Malaria,Falciparum | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03420053) |
| May 22, 2017 | NCT03163121 | Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers | Sanaria Inc. | Phase 1 | Completed | Malaria | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03163121) |
| August 9, 2016 | NCT02859350 | Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea. | Sanaria Inc. | Phase 1 | Completed | Malaria | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02859350) |
| March 10, 2016 | NCT02704533 | Sequential Optimization of Dose and Schedule of PfSPZ Vaccine | Sanaria Inc. | Phase 1 | Completed | Malaria | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02704533) |
| February 22, 2016 | NCT02687373 | Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya | Sanaria Inc. | Phase 1/2 | Completed | Malaria | 337 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02687373) |
| November 24, 2015 | NCT02613520 | Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants | Sanaria Inc. | Phase 1 | Completed | Malaria | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02613520) |
| November 10, 2015 | NCT02601716 | PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults | Sanaria Inc. | Phase 2 | Completed | Malaria | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02601716) |
| April 17, 2015 | NCT02418962 | Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults | Sanaria Inc. | Phase 1 | Completed | Malaria, Plasmodium Falciparum | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02418962) |
| September 11, 2014 | NCT02237586 | Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge | Sanaria Inc. | Phase 1 | Completed | Plasmodium Falciparum Malaria, Malaria | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02237586) |
| August 13, 2014 | NCT02215707 | A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs.... | Sanaria Inc. | Phase 1 | Completed | Malaria | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02215707) |
| May 7, 2014 | NCT02132299 | Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated... | Sanaria Inc. | Phase 1 | Completed | Malaria, Plasmodium Falciparum Malaria | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02132299) |
| April 16, 2014 | NCT02115516 | Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis | Sanaria Inc. | Phase 1 | Completed | Malaria, Plasmodium Falciparum Malaria | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02115516) |
| January 18, 2013 | NCT01771848 | Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults | Sanaria Inc. | Phase 1 | Completed | Malaria | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01771848) |
| November 20, 2012 | NCT01728701 | Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine... | Sanaria Inc. | Phase 1 | Completed | Malaria, Plasmodium Falciparum | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01728701) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 22 |
| Phase 1/2 | 1 |
| Phase 2 | 6 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 24 |
| Recruiting | 3 |
| Terminated | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Malaria, Falciparum | 29 |
| Malaria | 27 |
| Sickle Cell Trait | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Allergy and immunology practices in the United States](https://specstream.ai/data/businesses/allergy-and-immunology-practices/united-states)
- [Veterans hospitals in the United States](https://specstream.ai/data/businesses/veterans-hospitals/united-states)
- [Tax preparation firms in the United States](https://specstream.ai/data/businesses/tax-preparation-firms/united-states)
- [Senegalese restaurants in the United States](https://specstream.ai/data/businesses/senegalese-restaurants/united-states)
- [Prosthetics providers in the United States](https://specstream.ai/data/businesses/prosthetics-providers/united-states)
- [Pediatric cardiology practices in the United States](https://specstream.ai/data/businesses/pediatric-cardiology-practices/united-states)
